In AD-transgenic (APPSwe/PS1dE9) mice, supplementation with vitamin-D2-enriched mushrooms caused improvement in learning and memory, a reduction in amyloid plaque load and GFAP protein levels and an increase in anti-inflammatory interleukin-10 (IL-10) [102]. Here, GFAP is linked to Alzheimer disease.